294 related articles for article (PubMed ID: 27004408)
1. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells.
Kang J; Kim W; Kwon T; Youn H; Kim JS; Youn B
Oncotarget; 2016 Apr; 7(17):23961-74. PubMed ID: 27004408
[TBL] [Abstract][Full Text] [Related]
2. Inhibition on Numb/Notch signal pathway enhances radiosensitivity of lung cancer cell line H358.
Song SG; Yu HY; Ma YW; Zhang F; Xu XY
Tumour Biol; 2016 Oct; 37(10):13705-13719. PubMed ID: 27476167
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
Wang M; Wang W; Ding J; Wang J; Zhang J
Thorac Cancer; 2020 Feb; 11(2):379-388. PubMed ID: 31841274
[TBL] [Abstract][Full Text] [Related]
4. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
[TBL] [Abstract][Full Text] [Related]
5. DANGER is involved in high glucose-induced radioresistance through inhibiting DAPK-mediated anoikis in non-small cell lung cancer.
Kwon T; Youn H; Son B; Kim D; Seong KM; Park S; Kim W; Youn B
Oncotarget; 2016 Feb; 7(6):7193-206. PubMed ID: 26769850
[TBL] [Abstract][Full Text] [Related]
6. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
Yao YH; Cui Y; Qiu XN; Zhang LZ; Zhang W; Li H; Yu JM
Chin J Cancer; 2016 Jun; 35():50. PubMed ID: 27266881
[TBL] [Abstract][Full Text] [Related]
7. Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non-Small Cell Lung Cancer.
Sharma A; Bender S; Zimmermann M; Riesterer O; Broggini-Tenzer A; Pruschy MN
Clin Cancer Res; 2016 Sep; 22(17):4428-39. PubMed ID: 27076628
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells.
Gu Q; He Y; Ji J; Yao Y; Shen W; Luo J; Zhu W; Cao H; Geng Y; Xu J; Zhang S; Cao J; Ding WQ
Oncotarget; 2015 May; 6(13):10893-907. PubMed ID: 25843954
[TBL] [Abstract][Full Text] [Related]
9. Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.
Kang J; Kim E; Kim W; Seong KM; Youn H; Kim JW; Kim J; Youn B
J Biol Chem; 2013 Sep; 288(38):27343-27357. PubMed ID: 23902763
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-induced radioresistance is mediated by ROS-dependent inactivation of protein phosphatase 1 in non-small cell lung cancer cells.
Kim W; Youn H; Kang C; Youn B
Apoptosis; 2015 Sep; 20(9):1242-52. PubMed ID: 26033480
[TBL] [Abstract][Full Text] [Related]
11. LDR-Induced miR-30a and miR-30b Target the PAI-1 Pathway to Control Adverse Effects of NSCLC Radiotherapy.
Park G; Son B; Kang J; Lee S; Jeon J; Kim JH; Yi GR; Youn H; Moon C; Nam SY; Youn B
Mol Ther; 2019 Feb; 27(2):342-354. PubMed ID: 30424954
[TBL] [Abstract][Full Text] [Related]
12. Insufficient radiofrequency ablation promotes the growth of non-small cell lung cancer cells through PI3K/Akt/HIF-1α signals.
Wan J; Wu W; Chen Y; Kang N; Zhang R
Acta Biochim Biophys Sin (Shanghai); 2016 Apr; 48(4):371-7. PubMed ID: 26922319
[TBL] [Abstract][Full Text] [Related]
13. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance.
Che Y; Wang J; Li Y; Lu Z; Huang J; Sun S; Mao S; Lei Y; Zang R; Sun N; He J
Cell Death Dis; 2018 Jul; 9(7):759. PubMed ID: 29988148
[TBL] [Abstract][Full Text] [Related]
15. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.
Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J
Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759
[TBL] [Abstract][Full Text] [Related]
16. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 modulates radiation resistance through upregulation of hypoxia-inducible factor-1α-promoted glycolysis in non-small cell lung cancer cells.
Jiang S; Wang R; Yan H; Jin L; Dou X; Chen D
Mol Med Rep; 2016 May; 13(5):4101-7. PubMed ID: 27035555
[TBL] [Abstract][Full Text] [Related]
18. CLPTM1L induces estrogen receptor β signaling-mediated radioresistance in non-small cell lung cancer cells.
Li H; Che J; Jiang M; Cui M; Feng G; Dong J; Zhang S; Lu L; Liu W; Fan S
Cell Commun Signal; 2020 Sep; 18(1):152. PubMed ID: 32943060
[TBL] [Abstract][Full Text] [Related]
19. Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines.
Schilling D; Bayer C; Geurts-Moespot A; Sweep FC; Pruschy M; Mengele K; Sprague LD; Molls M
BMC Cancer; 2007 Jul; 7():143. PubMed ID: 17663760
[TBL] [Abstract][Full Text] [Related]
20. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]